Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
12/2014
12/10/2014CN104187254A 一种针对沙眼的食疗配方 One for trachoma diet recipes
12/10/2014CN104186867A 一种青果决明茶及其制备方法 One kind of fruit tea Cassia its preparation method
12/10/2014CN103393020B 利用绿豆皮制备保健蜜丸的方法 Pill use mung bean skin care preparation method
12/10/2014CN103193773B Vegf-r2的吡啶氧基吲哚类抑制剂及其用于治疗疾病的用途 Uses Vegf-r2 pyridyloxy indole inhibitors for the treatment of diseases and
12/10/2014CN103073620B Kdr肽和包括该肽的疫苗 Kdr peptides and vaccines comprising the peptide
12/10/2014CN103054840B 左旋沙丁胺醇在制备抗血管生成类药物中的应用 Levalbuterol in the preparation of anti-angiogenesis drug application
12/10/2014CN102884073B 用于促进血管生成的肽及其用途 For promoting angiogenesis peptides and uses thereof
12/10/2014CN102827226B 一种尿苷衍生物修饰的硅酞菁及其制备方法和应用 One kind of uridine derivatives modified silicon phthalocyanine and its preparation method and application
12/10/2014CN102812005B β-分泌酶抑制剂 β- secretase inhibitors
12/10/2014CN102014957B 用于治疗耳部疾病和病况的耳用调配物 Otic formulation for the treatment of otic diseases and conditions
12/09/2014US8906950 Ketorolac tromethamine compositions for treating or preventing ocular pain
12/09/2014US8906948 Choline cocrystal of epalrestat
12/09/2014US8906907 Hypotensive lipid and timolol compositions and methods of using same
12/09/2014US8906852 Inhibitors of protein tyrosine kinase activity
12/02/2014US8901111 Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase
12/02/2014US8900567 Treatment of cone cell degeneration with transfected lineage negative hematopoietic stem cells
11/2014
11/27/2014US20140349391 Method of collecting placental stem cells
11/25/2014US8895532 Use of hyaluronic acid for the preparation of compositions intended for improving in particular the protective function of the skin, the eye and the mucous membranes
11/25/2014US8895501 Eye-drop vaccine containing copolymer 1 for therapeutic immunization
11/20/2014US20140342405 Vascular endothelial growth factor 2
11/18/2014US8889135 Methods of administering anti-TNFα antibodies
11/13/2014US20140336158 Nk1 antagonists
11/13/2014US20140335549 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
11/11/2014US8883849 Treatment of sleep disturbances
11/11/2014US8883825 Aqueous liquid preparations and light-stabilized aqueous liquid preparations
11/11/2014US8883750 Method of treating diabetes
11/11/2014US8883738 Use of a peptide fragment of CD44v6 in the treatment of ophthalmic diseases
11/11/2014US8883504 Cell differentiation suppressing agent, method of culturing cells using the same, culture solution, and cultured cell line
11/11/2014US8882075 Furnace mount
11/06/2014US20140330007 2,4-pyrimidinediamine compounds and their uses
11/04/2014US8877814 Titration package for neramexane and its use in the treatment of an inner ear disorder
11/04/2014US8877804 Sulfur derivatives as chemokine receptor modulators
11/04/2014US8877229 Controlled release microparticles
10/2014
10/30/2014US20140325691 Regulation of endogenous gene expression in cells using zinc finger proteins
10/30/2014US20140322232 Methods of administering anti-tnfalpha antibodies
10/28/2014US8871813 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
10/28/2014US8871226 Methods and compositions for the treatment and diagnosis of cancer
10/21/2014US8865776 Use of low molecular weight amino alcohols in ophthalmic compositions
10/21/2014US8865654 Eye drops
10/21/2014US8865643 Recombinant surfactant protein D compositions and methods of use thereof
10/14/2014US8862224 Method for treating neovascularization
10/14/2014US8859729 Growth hormone releasing peptides
10/14/2014US8859525 Pharmaceutical compositions comprising mushroom-based polysaccharides and uses thereof
10/09/2014WO2014165181A1 Compositions for treatment of retinal detachment
10/09/2014WO2014164886A1 Prostanoid receptor agonist compounds and their use
10/09/2014WO2014164703A1 Delivery of card protein as therapy for occular inflammation
10/09/2014WO2014163142A1 Ophthalmic composition
10/09/2014WO2013102907A9 Ophthalmic composition
10/09/2014US20140303215 Topically applicable pharmaceutical preparation
10/09/2014US20140303154 2,4-pyridinediamine compounds and their uses
10/09/2014US20140303126 Novel quinuclidine derivatives and medicinal compositions containing the same
10/08/2014EP2785744A1 Protein inhibitors to complement and vegf pathways and methods of use thereof
10/08/2014EP2785739A1 Improving trabeculectomy outcome
10/08/2014EP2785363A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of dry eye syndrome
10/08/2014EP2785345A1 Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for retinal neuroprotection
10/08/2014EP2785338A1 Methods of treatment and prevention of eye diseases
10/08/2014EP2785328A1 Novel slow-releasing ophthalmic compositions comprising povidone iodine
10/07/2014US8853397 2,4-pyrimidinediamine compounds and their uses
10/07/2014US8853163 Methods for increasing vascular density and maintaining viability of microvascular endothelial cells using trk receptor ligands
10/02/2014WO2014160579A1 Combination anti-inflammatory ophthalmic compositions
10/02/2014WO2014160502A1 Uridine nucleoside derivatives, compositions and methods of use
10/02/2014WO2014160308A1 Systems and methods for treating ear disorders and formulations therefor
10/02/2014WO2014160079A1 Microemulsion topical delivery platform
10/02/2014WO2014159679A1 Methods for using lubiprostone to absorb fluid from the subretinal space
10/02/2014WO2014159546A1 Modified soluble vegf receptor-1 genes and vectors for gene therapy
10/02/2014WO2014157727A1 Therapeutic agent for eye disorder
10/02/2014WO2014157158A1 Phenyl derivative
10/02/2014WO2014154843A1 Modified tgf-beta2 oligonucleotides
10/02/2014WO2014154173A1 Anti-angiogenic compound
10/02/2014WO2014153733A1 Ophthalmic composition, method for preparing the same, and use of the same
10/02/2014WO2014153643A1 Compositions and methods for use thereof in the treatment of aniridia
10/02/2014US20140294935 Vaccine composition
10/02/2014US20140294857 Methods of obtaining a specific binding member that binds eotaxin
10/01/2014EP2783695A1 Physiological supplement or medicament for ophthalmic use containing L-carnitine or alkanoyl L-carnitines in combination with eledoisin
10/01/2014EP2783689A1 Keratoconjunctival protecting agent, or keratoconjunctival disorder inhibiting agent
10/01/2014EP2782903A1 Novel pyrrolidine derivatives as inhibitors of cathepsin
10/01/2014EP2782569A1 Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3h-imidazole derivatives for treating retinal diseases
09/2014
09/30/2014US8846688 Sodium channel blockers
09/30/2014US8846650 Method of treating middle ear infections
09/30/2014US8846409 Methods of preparing cannabinoids from plant material
09/30/2014CA2618871C Ophthalmic compositions containing mucoadhesive polysaccharides able to promote corneal re-epithelization
09/25/2014WO2014152818A1 Methods of inhibiting cataracts and presbyopia
09/25/2014WO2014152144A1 Muscarinic agonists
09/25/2014WO2014151703A1 Ocular formulations
09/25/2014WO2014151381A1 Bioerodible silicon-based compositions for delivery of therapeutic agents
09/25/2014WO2014150873A1 Sequestrants of advanced glycation end product (age) precursors
09/25/2014WO2014150067A1 Concentrated aqueous azalide formulations
09/25/2014WO2014148574A1 Inhibition of production of il-2
09/25/2014WO2014148455A1 Terpenoid derivative
09/25/2014US20140288266 Synthesis of Cyclosporin Analogs
09/24/2014EP2780358A1 Cyclosporine a form 2 and method of making same
09/24/2014EP2780022A1 Pharmaceutical preparations of human rpe cells and uses thereof
09/23/2014US8841261 Functional powdery product
09/23/2014US8841254 Method for treatment of anxiety
09/23/2014CA2631408C Composition having effect on treatment and prevention of dry eye syndrome
09/23/2014CA2628413C Prostaglandins and analogues as agents for lowering intraocular pressure
09/18/2014WO2014146044A1 Administration of nicotinamide mononucleotide in the treatment of disease
09/18/2014WO2014145986A1 Multisubstituted aromatic compounds as serine protease inhibitors
09/18/2014WO2014145308A1 Compositions and methods for delivering therapeutic and imaging agents to the sinuses and middle ear
09/18/2014WO2014145118A1 Resorufin derivatives for treatment of oxidative stress disorders
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... 531